Keep Your Formulation Safe With Parteck® M Excipient: API Stability Combined With Rapid Disintegration

Achieving a stable and reliable outcome in tablet manufacturing often requires intense processing and the application of high forces. However, with Parteck® M, one of our functional excipients, you can achieve excellent compressibility while maintaining the stability of the active pharmaceutical ingredient (API) throughout the manufacturing process and beyond. Parteck® M is based on directly compressible mannitol, which eliminates the need for further processing or the application of high forces. This excipient enables rapid disintegration and quick release of the API, regardless of the dosage. Whether your active ingredients are high- or low-dosed, Parteck® M ensures a swift and efficient release to enhance the overall effectiveness of your tablets.
Discover how incorporating Parteck® M into your tablet formulations can streamline your manufacturing process, reduce the need for intense processing, and ensure the stability and efficacy of your products.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.